Optimized Psychiatry Clinical Trials As A Path To Fixing The Severe Mental Illness Care Access Gap

Patients with severe mental illness (SMI) face significant barriers to accessing clinical trials, contributing to their higher risk of premature death from untreated somatic illnesses. Elligo Health Research offers a solution through optimized clinical trials, which blend healthcare-first site visits with virtual processes supported by HIPAA-compliant electronic health record (EHR) data and AI-powered analytics.

These trials effectively address the challenges faced by SMI patients, such as transportation, stigmatization, and reduced functioning, by bringing research directly to them in familiar, supportive environments. A study from Denmark highlights the importance of familiar healthcare providers in successful recruitment, underscoring the potential of Elligo’s model. Additionally, Elligo’s advanced AI technology overcomes issues related to incomplete or inaccurate EHR data, ensuring rapid and accurate patient identification and enrollment.

By breaking down research access barriers, Elligo's approach not only enhances trial participation but also promises to improve mental healthcare outcomes for patients with SMI.